Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.
暂无分享,去创建一个
[1] B. Zinman,et al. Bioelectrical impedance analysis (BIA) using bipolar foot electrodes in the assessment of body composition in Type 2 diabetes mellitus , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[2] T. Chou,et al. Alterations of nitric oxide synthase expression with aging and hypertension in rats. , 1998, Hypertension.
[3] J. Mcgiff,et al. Tumor necrosis factor‐α‐angiotensin interactions and regulation of blood pressure , 1997 .
[4] J S Yudkin,et al. Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .
[5] C. Mantzoros,et al. Leptin concentrations in relation to body mass index and the tumor necrosis factor-α system in humans , 1997 .
[6] S. Umemura,et al. Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats. , 1997, Hypertension.
[7] W. Ricart,et al. The TNF-α Gene Neo I Polymorphism Influences the Relationship Among Insulin Resistance, Percent Body Fat, and Increased Serum Leptin Levels , 1997, Diabetes.
[8] Margaret S. Wu,et al. Targeted Disruption of the Tumor Necrosis Factor-α Gene: Metabolic Consequences in Obese and Nonobese Mice , 1997, Diabetes.
[9] S B Heymsfield,et al. Bioimpedance analysis: evaluation of leg-to-leg system based on pressure contact footpad electrodes. , 1997, Medicine and science in sports and exercise.
[10] A. Pfeiffer,et al. Circulating Tumor Necrosis Factor α is Elevated in Male but Not in Female Patients With Type II Diabetes Mellitus , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[11] B. Spiegelman,et al. Differential Regulation of the p80 Tumor Necrosis Factor Receptor in Human Obesity and Insulin Resistance , 1997, Diabetes.
[12] B. Zinman,et al. The Prevalence of NIDDM and Associated Risk Factors in Native Canadians , 1997, Diabetes Care.
[13] J. Stephens,et al. Tumor Necrosis Factor-α-induced Insulin Resistance in 3T3-L1 Adipocytes Is Accompanied by a Loss of Insulin Receptor Substrate-1 and GLUT4 Expression without a Loss of Insulin Receptor-mediated Signal Transduction* , 1997, The Journal of Biological Chemistry.
[14] L. Groop,et al. Circulating TNF-alpha and Leptin Levels in Offspring of NIDDM Patients Do Not Correlate to Individual Insulin Sensitivity , 1996, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[15] B. Zinman,et al. Use of Ethnographic Methods for Applied Research on Diabetes Among the Ojibway-Cree in Northern Ontario , 1996, Health education quarterly.
[16] Roy Taylor,et al. Effects of an Engineered Human Anti–TNF-α Antibody (CDP571) on Insulin Sensitivity and Glycemic Control in Patients With NIDDM , 1996, Diabetes.
[17] R. McCarron,et al. Evidence for activation of endothelium and monocytes in hypertensive rats. , 1996, The American journal of physiology.
[18] B. Spiegelman,et al. Tumor Necrosis Factor (TNF)-α Inhibits Insulin Signaling through Stimulation of the p55 TNF Receptor and Activation of Sphingomyelinase* , 1996, The Journal of Biological Chemistry.
[19] M. Papa,et al. Sphingomyelinase and Ceramide Suppress Insulin-induced Tyrosine Phosphorylation of the Insulin Receptor Substrate-1 (*) , 1996, The Journal of Biological Chemistry.
[20] D. Moller,et al. Candidate Genes for Insulin Resistance , 1996, Diabetes Care.
[21] M. Sormani,et al. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis. , 1996, Annals of the rheumatic diseases.
[22] A. Brasier,et al. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. , 1996, Hypertension.
[23] W A Buurman,et al. Tumor necrosis factor: function, release and clearance. , 1996, Critical reviews in immunology.
[24] M. Papa,et al. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. , 1995, The Journal of biological chemistry.
[25] S. Haffner. Risk factors for non-insulin-dependent diabetes mellitus , 1995, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[26] E. Ravussin,et al. Linkage between obesity and a marker near the tumor necrosis factor-alpha locus in Pima Indians. , 1995, The Journal of clinical investigation.
[27] C. Mantzoros,et al. Genetic Variability in the TNF-α Promoter Is Not Associated with Type II Diabetes Mellitus (NIDDM) , 1995 .
[28] R. Simsolo,et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. , 1995, The Journal of clinical investigation.
[29] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[30] G. Salles,et al. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. , 1995, European cytokine network.
[31] D. Fuchs,et al. Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus , 1995, Lupus.
[32] G. Tilz,et al. Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis , 1995, European journal of haematology.
[33] B. Spiegelman,et al. Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.
[34] B. Spiegelman,et al. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha. , 1994, The Journal of clinical investigation.
[35] B. Spiegelman,et al. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[37] H. Delisle,et al. Prevalence of non-insulin-dependent diabetes mellitus and impaired glucose tolerance in two Algonquin communities in Quebec. , 1993, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[38] S. Joel,et al. Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. , 1992, Journal of immunological methods.
[39] P. Dawson. Effect of formulation and freeze-drying on the long-term stability of rDNA-derived cytokines. , 1992, Developments in biological standardization.
[40] P. Zimmet,et al. Hyperinsulinaemia is a predictor of non-insulin-dependent diabetes mellitus. , 1991, Diabete & metabolisme.
[41] R. DeFronzo,et al. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.
[42] G. Reaven. Role of Insulin Resistance in Human Disease , 1988, Diabetes.
[43] T. K. Young. Health Care and Cultural Change: The Indian Experience in the Central Subarctic , 1988 .
[44] T. K. Young. Are subarctic Indians undergoing the epidemiologic transition? , 1988, Social science & medicine.
[45] L. Mcintyre,et al. Prevalence of hypertension, obesity and smoking in three Indian communities in northwestern Ontario. , 1986, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[46] Diabetes mellitus. Report of a WHO Study Group. , 1985, World Health Organization technical report series.